Raia Drogasil S.A. (RADLY) Q2 2026 Earnings Call Transcript
Raia Drogasil S.A. (RADLY) Q1 2026 Earnings Call Transcript
Raia Drogasil S.A. (OTCMKTS:RADLY - Get Free Report) was the target of a significant increase in short interest in the month of February. As of February 27th, there was short interest totaling 8,015 shares, an increase of 138.8% from the February 12th total of 3,356 shares. Based on an average daily volume of 13,990 shares,
| Pharmaceuticals Industry | Healthcare Sector | Renato Raduan CEO | OTC PINK Exchange | 750723108 CUSIP |
| BR Country | 73,895 Employees | 13 Jul 2026 Last Dividend | 24 Dec 2025 Last Split | - IPO Date |
Raia Drogasil S.A. stands as a prominent entity in the Brazilian retail market, specializing in the distribution and sale of a broad spectrum of health and beauty products. Founded in 1905, the company has established a strong foothold in the industry, navigating through the evolving consumer needs and the dynamic pharmaceutical landscape in Brazil. As of March 31, 2022, Raia Drogasil S.A. boasts an extensive network, operating 2,530 drug stores across 26 Brazilian states. The company’s commitment to accessibility and customer satisfaction extends beyond brick-and-mortar outlets, utilizing telesales and leveraging three call centers strategically located in São Paulo, Tocantins, and Pernambuco to enhance its reach and service delivery. Headquartered in São Paulo, Brazil, Raia Drogasil S.A.'s enduring legacy and continuous growth underscore its pivotal role in the retail pharmacy sector, driven by a relentless pursuit of excellence and innovation in meeting the healthcare and beauty needs of its clientele.
Raia Drogasil S.A. provides a comprehensive range of medicines, encompassing both prescription and over-the-counter (OTC) options to meet the healthcare needs of its customers. The company ensures a wide selection of pharmaceuticals to address various health concerns, from common ailments to chronic conditions, emphasizing quality and reliability.
Understanding the growing consumer demand for personal care and beauty products, Raia Drogasil S.A. offers an expansive assortment of items in these categories. From daily hygiene essentials to luxury beauty brands, the company caters to diverse preferences and budgets, ensuring its customers find everything they need for their personal care routines under one roof.
The company also delves into the specialized segment of cosmetics and dermocosmetics, providing products designed to meet the skincare needs of its clientele. Raia Drogasil S.A. curates a selection of high-quality brands known for their effectiveness and skincare benefits, addressing everything from basic skincare to specific dermatological concerns.
Raia Drogasil S.A.’s catalog includes specialty medicines that cater to patients with specific and often complex medical conditions. These high-value pharmaceuticals require special handling, storage, and administration, underscoring the company’s commitment to offering comprehensive healthcare solutions that extend to specialized care needs.
Beyond its physical retail presence, Raia Drogasil S.A. innovatively uses telesales and operates three call centers in São Paulo, Tocantins, and Pernambuco. These channels aim to augment the shopping experience, offering convenience to customers preferring to order their products remotely, ensuring timely delivery of medicines and products directly to their doorsteps. This service highlights the company’s adaptability and forward-thinking approach in catering to evolving customer preferences and the trend towards digital retailing within the pharmacy sector.